Eva Corey
968 works · 15,300 citations · h-index 66
Top works
- Tumor-induced anorexia and weight loss are mediated by the TGF-β superfamily cytokine MIC-1
- Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers
- Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate.
- The Androgen-Regulated Protease TMPRSS2 Activates a Proteolytic Cascade Involving Components of the Tumor Microenvironment and Promotes Prostate Cancer Metastasis
- Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling
- Basic Mechanisms Responsible for Osteolytic and Osteoblastic Bone Metastases
- Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer
- LuCaP 35: A new model of prostate cancer progression to androgen independence
- Osteoprotegerin and rank ligand expression in prostate cancer
- Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer.
- Improved reverse transcriptase–polymerase chain reaction protocol with exogenous internal competitive control for prostate-specific antigen mRNA in blood and bone marrow
- Establishment and characterization of osseous prostate cancer models: Intra‐tibial injection of human prostate cancer cells
- Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer
- Prostatic cell lineage markers: Emergence of BCL2 cells of human prostate cancer xenograft LuCaP 23 following castration
- Elevation of cytokine levels in cachectic patients with prostate carcinoma
- Androgen Receptor Splice Variants Determine Taxane Sensitivity in Prostate Cancer
- Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway
- Detection of disseminated prostate cells by reverse transcription-polymerase chain reaction (RT-PCR): Technical and clinical aspects
- Identification of differentially expressed prostate genes: Increased expression of transcription factor ETS-2 in prostate cancer
- Serum osteoprotegerin levels are increased in patients with advanced prostate cancer.